论文部分内容阅读
目的进一步对在急性加重期慢性阻塞性肺疾病的治疗中采用丹参注射液的临床应用价值安全性进行分析和探讨。方法选取我院于2012年10月—2014年10月期间所收治的100例急性加重期慢性阻塞性肺疾病患者,将其作为本次的研究对象,并分成对照组和观察组,每组各50例,对照组患者进行常规治疗,观察组患者在此基础上联合丹参注射液进行治疗,观察两组患者的治疗效果,并进行比较。结果经过治疗后,两组患者的病情均得到不同程度改善,观察组总有效率92%,对照组总有效率76%,治疗期间,患者均没有出现较为明显的不良反应。结论在急性加重期慢性阻塞性肺疾病患者的治疗过程中,通过常规治疗联合丹参注射液能够有效改善患者的病情,提高治疗效果,在临床上具有极为重要的意义,今后值得推广和应用。
Objective To further analyze the clinical value of Salvia miltiorrhiza injection in the treatment of chronic obstructive pulmonary disease in acute exacerbation. Methods A total of 100 patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) admitted from October 2012 to October 2014 in our hospital were selected as the study subjects and divided into control group and observation group 50 patients in the control group were treated routinely. The patients in the observation group were treated with Salvia miltiorrhiza injection on the basis of the above, and the therapeutic effects of the two groups were observed and compared. Results After treatment, the two groups of patients were improved to varying degrees, the total effective rate of 92% in the observation group, the control group, the total effective rate of 76%, during treatment, patients did not appear more obvious adverse reactions. Conclusion In the treatment of acute exacerbation chronic obstructive pulmonary disease patients, the routine treatment combined with Salvia injection can effectively improve the patient’s condition and improve the therapeutic effect, which is of clinical significance. It is worthy of promotion and application in the future.